Announcements Trials
Browse Landscape

Phase

Phase 2 35Phase 1 24Phase 1/2 19Phase EARLY_PHASE1 5Phase NA 2Phase 4 1Phase 3 1Phase 2/3 1

Status

Completed 2Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 2Plasma cell 1Gastrointestinal 1Dermatologic 1

Conditions

Resectable Localized Prostate Cancer 1Prostatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasms, Plasma Cell 1Melanoma 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Hydroxychloroquine × Clear all
NCT05365893 2026-05-22

PHL Treatment in Pancreatic Cancer

Fox Chase Cancer Center

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT06408298 2026-02-04

HCQ in Resectable Localized Prostate Cancer

Dartmouth-Hitchcock Medical Center

Phase EARLY_PHASE1 Recruiting
20 enrolled
Genitourinary

Resectable Localized Prostate Cancer

NCT00962845 2022-09-07

Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Rutgers, The State University of New Jersey

Phase EARLY_PHASE1 Completed
20 enrolled
Dermatologic

Melanoma

NCT02421575 2017-02-02

Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance

Rutgers, The State University of New Jersey

Phase EARLY_PHASE1 Terminated
4 enrolled
Genitourinary

Prostatic Neoplasms

NCT01396200 2013-02-26

Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Completed
6 enrolled
Plasma cell

Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡